Blog Posts by Tag: Outsourced Billing
Measuring Real Client Profitability for Diagnostic Providers with Large National Sales Teams
Finance and sales executives for diagnostics companies with large national sales teams are becoming sophisticated in measuring sales productivity in terms of number of calls, revenue per client, revenue per rep, and even revenue per call. To better serve clients and patients, providers can leverage analytics covering the full transaction cycle—order-to-cash—to determine actual client...
Outsourcing Your Billing Processes: When does it make sense for outpatient diagnostic services?
From IT and EHR support to back-office functions, hospitals are increasingly turning to business process outsourcing (BPO) to relieve staffing and financial pressures. Within the hospital ecosystem – where technology and processes are typically optimized for high-acuity clinical encounters – outpatient and ancillary services departments can find it difficult to overcome their unique business...
Automation Strategies for Molecular Diagnostic Market-Share Expansion
This blog post is the third in our series covering the keys to success for market-share expansion in molecular diagnostics based on our recently published whitepaper, “The Executive’s Guide to Molecular Diagnostic Market-Share Expansion”. If you missed either of the first two posts in this series, you can find the first post, “Molecular Diagnostic Market-Share Expansion: Keys to Success” here and...
The Importance of Physician and Patient Engagement for Molecular Diagnostic Market-Share Expansion
This blog is the second in our series covering the keys to success for market-share expansion in molecular diagnostics outlined in our recent whitepaper, “The Executive’s Guide to Molecular Diagnostic Market-Share Expansion”. We encourage you to read Part 1 and Part 3.As more molecular diagnostic testing moves from physician offices and laboratories to the home, molecular diagnostics...
No Surprises Act: 2023 Changes and Clarifications
Effective January 1, 2022, the No Surprises Act (NSA) established new federal protections against surprise medical bills and balance billing for services received from out-of-network providers.Since January 2022, CMS has published over 50 resources related to the Act, five of which were released as recently as December. In August 2022, CMS issued the final rules, entitled “Requirements Related to...
Molecular Diagnostic Market-Share Expansion: Keys to Success
This blog is part of a series. We encourage you to read Part 2 here and Part 3. The molecular diagnostics market has experienced tremendous growth in recent years. It’s a complex business with many challenges, including prior authorization requirements, diagnostic coding changes, the evolving regulatory landscape, and specimen collection moving from physician offices and laboratories to the home...
Quick Wins to Mitigate Hospital Staffing Challenges
In its annual survey, the American College of Healthcare Executives (ACHE) asked community hospital CEOs to rank 11 issues facing their organizations. Personnel and staffing shortages leapt to the forefront – ranked as the number-one concern for the first time since 2004. Equally noteworthy, staffing shortages skyrocketed from an average ranking of 4.6 of 11 in 2019 to 1.6 in 2021. RNs topped the...
Top 5 Blog Posts of 2022
As always, XiFin's Beyond Billing blog kept abreast of key issues and hot topics within the healthcare industry, staying especially in tune with legislative proposals that can potentially impact reimbursement and revenue.Here are the top blogs of 2022, with far-ranging topics that include PAMA and SALSA, the No Surprises Act, digital pathology, and revenue cycle management. 1. Laboratory Test...
- 1 of 4
- next ›